clinical development of CNS therapies

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. It focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia, and develops therapeutic options with novel mechanisms of action. The company was founded in January 2012 and is headquartered at One World Trade Center, New York, NY.

Read more

biopharmaceutical research and development